May 16, 2023 Drug Pricing Transparency Congress IntegriChain, delivering pharma’s only comprehensive technology, data, consulting, and outsourcing platform for data-driven commercialization, announced that pharmaceutical pricing and regulatory expert and Vice President of Operational Consulting Jeff Baab spoke on the impact of the Inflation Reduction Act (IRA) at Informa’s Medicaid & Government Pricing Congress, from May 16-18 in Washington, DC. This conference was held in conjunction with the Drug Pricing Transparency Congress, of which IntegriChain is a sponsor, and the Life Sciences Contracting & Pricing USA Conference. This session was available to attendees of all three conferences. Jeff BaabVice President, Operational Consulting Session: Updated Review and Interpretation of the Inflation Reduction Act Date/Time: May 17, 2023 9:45 – 10:25 AM Session Description: Jeff Baab participated in a panel discussion with Endo Pharmaceuticals, providing a refresher overview of the Inflation Reduction Act and how it will affect you and your company – both for commercial and GP department Approaches to projections on accruals Tips and tricks to calculate PBM perspective on whether a rebate will be in place Do PBMs see the IRA price negotiation as a negative or benefit? Learn more about how our operational consulting team helps manufacturers meet today’s complex commercial and government access challenges.
